<DOC>
	<DOCNO>NCT02967055</DOCNO>
	<brief_summary>This exploratory study fill knowledge gap regard pharmacokinetic effect isotretinoin etonogestrel ( ENG ) contraceptive implant .</brief_summary>
	<brief_title>The Effect Isotretinoin Etonogestrel Contraceptive Implant</brief_title>
	<detailed_description>The Investigators enroll woman etonogestrel contraceptive implant place initiate isotretinoin therapy dermatologist . The Investigators monitor subject serum etonogestrel concentration isotretinoin therapy medication provide study . No medical device insert part study either .</detailed_description>
	<mesh_term>Isotretinoin</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<criteria>Have secondary form nonhormonal contraception abstain isotretinoin therapy four week afterwards Have least two negative pregnancy test least 19 day apart prior initiate isotretinoin therapy Have normal baseline laboratory evaluation include liver function test , basic metabolic panel , complete blood count Willing abstain take Vitamin A supplement study period Have BMI &gt; = 18.5 Currently breastfeed Known contraindication isotretinoin Currently take know cytochrome P450 3A4 enzyme inducer inhibitor</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>